{"title":"Clinical Trial Participant's Perspectives on Genetic Research Data Re-uses for Future Research","authors":"R. Devarinti, M. S. Ganachari","doi":"10.2174/0118756921305151240503075928","DOIUrl":null,"url":null,"abstract":"\n\nClinical trial participants play a crucial role in advancing medical\nresearch, and the data generated from their participation can indeed be invaluable for\nfuture studies. However, the reuse of genetic or clinical research data comes with ethical\nchallenges that need careful consideration. Here are some of the key ethical issues associated\nwith the re-use of such data: Reusing data without clear informed consent raises issues\nof autonomy and respect for individuals' choices.\n\n\n\nThe main aim of this study is to assess the understanding of individuals involved\nin clinical trials regarding the sharing of genetic research information. Moreover,\nit seeks to explore the ethical issues and benefits linked with the use of genetic research\ndata for future research initiatives.\n\n\n\nA cross-sectional observational study was applied to assess\nKnowledge Attitude Practices of clinical trial participants on reuse of genetic research data.\n\n\n\nThe majority 70% of clinical trial participants were unsure about the difficulties\nthat may arise in future regarding the re-use of genomic data, with concerns about confidentiality\nbeing the most common.\n\n\n\nThe present study prioritized the involvement of clinical trial participants\ndue to their critical role in both genetic and clinical research endeavors. There is a lack of\nawareness and understanding regarding the re-use of genetic sample data and ethical issues\namong the trial participants. Researchers must take measures to de-identify or anonymize\ndata to protect participants. There is a clear need for comprehensive awareness\nprograms and guidelines aimed at all clinical trial stakeholders. These initiatives would\nensure that researchers, participants, and other involved parties are well-informed and adhere\nto ethical standards when utilizing genetic data for subsequent research endeavors.\n","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"120 30","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0118756921305151240503075928","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Clinical trial participants play a crucial role in advancing medical
research, and the data generated from their participation can indeed be invaluable for
future studies. However, the reuse of genetic or clinical research data comes with ethical
challenges that need careful consideration. Here are some of the key ethical issues associated
with the re-use of such data: Reusing data without clear informed consent raises issues
of autonomy and respect for individuals' choices.
The main aim of this study is to assess the understanding of individuals involved
in clinical trials regarding the sharing of genetic research information. Moreover,
it seeks to explore the ethical issues and benefits linked with the use of genetic research
data for future research initiatives.
A cross-sectional observational study was applied to assess
Knowledge Attitude Practices of clinical trial participants on reuse of genetic research data.
The majority 70% of clinical trial participants were unsure about the difficulties
that may arise in future regarding the re-use of genomic data, with concerns about confidentiality
being the most common.
The present study prioritized the involvement of clinical trial participants
due to their critical role in both genetic and clinical research endeavors. There is a lack of
awareness and understanding regarding the re-use of genetic sample data and ethical issues
among the trial participants. Researchers must take measures to de-identify or anonymize
data to protect participants. There is a clear need for comprehensive awareness
programs and guidelines aimed at all clinical trial stakeholders. These initiatives would
ensure that researchers, participants, and other involved parties are well-informed and adhere
to ethical standards when utilizing genetic data for subsequent research endeavors.
期刊介绍:
Current Pharmacogenomics and Personalized Medicine (Formerly ‘Current Pharmacogenomics’) Current Pharmacogenomics and Personalized Medicine (CPPM) is an international peer reviewed biomedical journal that publishes expert reviews, and state of the art analyses on all aspects of pharmacogenomics and personalized medicine under a single cover. The CPPM addresses the complex transdisciplinary challenges and promises emerging from the fusion of knowledge domains in therapeutics and diagnostics (i.e., theragnostics). The journal bears in mind the increasingly globalized nature of health research and services.